Patents by Inventor Franco Borsini

Franco Borsini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING SEXUAL DESIRE DISORDERS WITH FLIBANSERIN
    Publication number: 20210308129
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: June 18, 2021
    Publication date: October 7, 2021
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 11058683
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: July 13, 2021
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • TREATING SEXUAL DESIRE DISORDERS WITH FLIBANSERIN
    Publication number: 20200281922
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: April 30, 2020
    Publication date: September 10, 2020
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 10675280
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: June 9, 2020
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • TREATING SEXUAL DESIRE DISORDERS WITH FLIBANSERIN
    Publication number: 20190262336
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 10307420
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: June 4, 2019
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20190000842
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 10098876
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: October 16, 2018
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20180055839
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: September 1, 2017
    Publication date: March 1, 2018
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 9782403
    Abstract: The invention relates to the use of fibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: October 10, 2017
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20170100392
    Abstract: The invention relates to the use of fibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: September 20, 2016
    Publication date: April 13, 2017
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 9468639
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: October 18, 2016
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20150342948
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: March 6, 2015
    Publication date: December 3, 2015
    Inventors: Franco Borsini, Kenneth Robert Evans
  • METHOD OF USING FLIBANSERIN FOR NEUROPROTECTION
    Publication number: 20150057290
    Abstract: The present invention relates to the use of 1-[2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazol-2-one, optionally in the form of its pharmaceutically acceptable acid addition salts and optionally in the form of its hydrates or solvates, for preparing a pharmaceutical composition with a neuroprotective activity.
    Type: Application
    Filed: June 30, 2014
    Publication date: February 26, 2015
    Inventor: Franco Borsini
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20150011563
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: May 5, 2014
    Publication date: January 8, 2015
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20140057923
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: June 18, 2013
    Publication date: February 27, 2014
    Inventors: Franco Borsini, Kenneth Robert Evans
  • METHOD OF USING FLIBANSERIN FOR NEUROPROTECTION
    Publication number: 20140044803
    Abstract: The present invention relates to the use of 1-[2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazol-2-one, optionally in the form of its pharmaceutically acceptable acid addition salts and optionally in the form of its hydrates or solvates, for preparing a pharmaceutical composition with a neuroprotective activity.
    Type: Application
    Filed: May 31, 2013
    Publication date: February 13, 2014
    Inventor: Franco Borsini
  • Treating Sexual Desire Disorders with Flibanserin
    Publication number: 20130096137
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Application
    Filed: July 17, 2012
    Publication date: April 18, 2013
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Treating sexual desire disorders with flibanserin
    Patent number: 8227471
    Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: July 24, 2012
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Franco Borsini, Kenneth Robert Evans
  • Method of Using Flibanserin for Neuroprotection
    Publication number: 20120035185
    Abstract: The present invention relates to the use of 1-[2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazol-2-one, optionally in the form of its pharmaceutically acceptable acid addition salts and optionally in the form of its hydrates or solvates, for preparing a pharmaceutical composition with a neuroprotective activity.
    Type: Application
    Filed: October 19, 2011
    Publication date: February 9, 2012
    Inventor: Franco Borsini